A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
James A. Trofatter1, Mia M. MacCollin1, Joni L. Rutter1, Jill R. Murrell1, Mabel P. Duyao1, Dilys M. Parry2, Roswell Eldridge3, Nikolai Kley4, Anil G. Menon5, Karen Pulaski1, Volker H. Haase1, Christine M. Ambrose1, David Munroe6, Catherine Bove1, Jonathan L. Haines1, Robert L. Martuza7, Marcy E. MacDonald1, Bernd R. Seizinger4, M.Priscilla Short1, Alan J. Buckler1
1Molecular Neurogenetics Unit Massachusetts General Hospital and Harvard Medical School Charlestown, Massachusetts 02129 USA
2Clinical Epidemiology Branch National Cancer Institute Bethesda, Maryland 20892 USA
3US Public Health Service Bethesda, Maryland 20892 USA
4Oncology Drug Discovery Bristol-Myers Squibb Pharmaceutical Research Institute Princeton, New Jersey 08543 USA
5Department of Molecular Genetics University of Cincinnati Medical Center Cincinnati, Ohio 45267 USA
6Center for Cancer Research Massachusetts Institute of Technology Cambridge, Massachusetts 02139 USA
7Department of Neurosurgery Georgetown University Medical Center Washington, DC 20007 USA